Growth Metrics

Integra Lifesciences Holdings (IART) Non-Current Deferred Tax Liability (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deferred Tax Liability fell 97.85% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, down 97.85% year-over-year, with the annual reading at $5.7 million for FY2025, 97.85% down from the prior year.
  • Non-Current Deferred Tax Liability hit $5.7 million in Q4 2025 for Integra Lifesciences Holdings, down from $58.3 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $263.4 million in Q4 2024 to a low of $5.7 million in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $82.4 million across 5 years, with a median of $64.4 million in 2021.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 924.31% in 2021 and later tumbled 97.85% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $169.8 million in 2021, then rose by 28.56% to $218.3 million in 2022, then plummeted by 83.82% to $35.3 million in 2023, then skyrocketed by 645.79% to $263.4 million in 2024, then crashed by 97.85% to $5.7 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for IART at $5.7 million in Q4 2025, $58.3 million in Q3 2025, and $60.1 million in Q2 2025.